The immunologic classification of tumors as “hot” or “cold” is determined by parameters that include the presence of specific tumor-infiltrating lymphocytes (TILs) such as CD4+ and CD8+ T cells, high TMB, as well as expression and recognition of neoantigens via MHC molecules by APCs. This evidence concerns the gene HLA-C and neoplasm.